InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Rapport Therapeutics, Inc.

RAPP Clue Score46
United States Fiscal year ends December CIK 0002012593 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

87
Insider
Date
Role
Action
Shares
Price
Amount
Abraham Ceesay
21 Oct 2026
Chief Executive Officer
Sold on a plan
2,210
$29.16
$64.45K
Abraham Ceesay
7 Oct 2026
Chief Executive Officer
Sold on a plan
1,147
$30.66
$35.17K
Abraham Ceesay
6 Oct 2026
Chief Executive Officer
Sold on a plan
3,375
$32.03
$108.11K
Cheryl Gault
30 Sep 2026
Chief Operating Officer
Sold on a plan
2,075
$33.76
$70.04K
Cheryl Gault
30 Sep 2026
Chief Operating Officer
Sold on a plan
7,925
$33.04
$261.81K
Abraham Ceesay
23 Sep 2026
Chief Executive Officer
Sold on a plan
43
$41.05
$1.77K
Abraham Ceesay
23 Sep 2026
Chief Executive Officer
Sold on a plan
215
$39.86
$8.57K
Abraham Ceesay
23 Sep 2026
Chief Executive Officer
Sold on a plan
1,952
$39.05
$76.23K
Abraham Ceesay
8 Sep 2026
Chief Executive Officer
Sold on a plan
1,069
$46.01
$49.19K
Abraham Ceesay
8 Sep 2026
Chief Executive Officer
Sold on a plan
7,141
$45.56
$325.31K
Krishnaswamy Yeleswaram
25 Aug 2026
Chief Development Officer
Sold on a plan
16,201
$51.06
$827.18K
Krishnaswamy Yeleswaram
25 Aug 2026
Chief Development Officer
Sold on a plan
20,799
$50.31
$1.05M
Abraham Ceesay
25 Aug 2026
Chief Executive Officer
Sold on a plan
18,921
$49.57
$937.96K
Krishnaswamy Yeleswaram
24 Aug 2026
Chief Development Officer
Sold on a plan
13,160
$50.00
$657.98K
Krishnaswamy Yeleswaram
19 Aug 2026
Chief Development Officer
Sold on a plan
404
$49.90
$20.16K
Abraham Ceesay
11 Aug 2026
Chief Executive Officer
Sold on a plan
5,794
$48.62
$281.72K
Abraham Ceesay
11 Aug 2026
Chief Executive Officer
Sold on a plan
19,500
$48.04
$936.85K
Abraham Ceesay
11 Aug 2026
Chief Executive Officer
Sold on a plan
3,664
$46.90
$171.84K
Abraham Ceesay
10 Aug 2026
Chief Executive Officer
Sold on a plan
8,370
$46.75
$391.28K
Abraham Ceesay
10 Aug 2026
Chief Executive Officer
Sold on a plan
14,171
$45.97
$651.49K
Abraham Ceesay
27 Jul 2026
Chief Executive Officer
Sold on a plan
7
$42.74
$299.15
Abraham Ceesay
27 Jul 2026
Chief Executive Officer
Sold on a plan
2,203
$42.11
$92.76K
Abraham Ceesay
14 Jul 2026
Chief Executive Officer
Sold on a plan
2,729
$40.57
$110.72K
Abraham Ceesay
14 Jul 2026
Chief Executive Officer
Sold on a plan
5,481
$39.72
$217.71K
Cheryl Gault
30 Jun 2026
Chief Operating Officer
Sold on a plan
1,000
$43.15
$43.15K
Cheryl Gault
30 Jun 2026
Chief Operating Officer
Sold on a plan
3,308
$42.17
$139.51K
Cheryl Gault
30 Jun 2026
Chief Operating Officer
Sold on a plan
3,792
$41.39
$156.96K
Cheryl Gault
30 Jun 2026
Chief Operating Officer
Sold on a plan
1,900
$40.09
$76.17K
Abraham Ceesay
29 Jun 2026
Chief Executive Officer
Sold on a plan
876
$40.34
$35.34K
Abraham Ceesay
29 Jun 2026
Chief Executive Officer
Sold on a plan
7,344
$39.77
$292.06K
Third Rock Ventures V, L.P.
26 May 2026
10% owner
Sold on a plan
18,572
$40.05
$743.75K
Third Rock Ventures V, L.P.
11 May 2026
10% owner
Sold on a plan
133,618
$40.24
$5.38M
Third Rock Ventures V, L.P.
8 May 2026
10% owner
Sold on a plan
5,018
$40.31
$202.26K
Third Rock Ventures V, L.P.
7 May 2026
10% owner
Sold on a plan
271,495
$40.12
$10.89M
Krishnaswamy Yeleswaram
17 Apr 2026
Chief Development Officer
Sold on a plan
20,225
$39.99
$808.84K
Third Rock Ventures V, L.P.
17 Apr 2026
10% owner
Sold on a plan
426,005
$40.32
$17.18M
Krishnaswamy Yeleswaram
14 Apr 2026
Chief Development Officer
Sold on a plan
10,200
$35.08
$357.80K
Krishnaswamy Yeleswaram
13 Apr 2026
Chief Development Officer
Sold on a plan
9,165
$34.97
$320.54K
Krishnaswamy Yeleswaram
10 Apr 2026
Chief Development Officer
Sold on a plan
500
$34.98
$17.49K
Krishnaswamy Yeleswaram
8 Apr 2026
Chief Development Officer
Sold on a plan
360
$34.90
$12.56K
Cheryl Gault
30 Mar 2026
Chief Operating Officer
Sold on a plan
2,839
$28.55
$81.06K
Cheryl Gault
30 Mar 2026
Chief Operating Officer
Sold on a plan
7,161
$28.04
$200.80K
Krishnaswamy Yeleswaram
25 Mar 2026
Chief Development Officer
Sold on a plan
10,115
$29.99
$303.35K
Abraham Ceesay
18 Feb 2026
Chief Executive Officer
Sold on a plan indirect
2,100
$29.80
$62.57K
Abraham Ceesay
18 Feb 2026
Chief Executive Officer
Sold on a plan indirect
2,983
$29.04
$86.64K
Abraham Ceesay
18 Feb 2026
Chief Executive Officer
Sold on a plan
2,281
$29.80
$67.97K
Abraham Ceesay
18 Feb 2026
Chief Executive Officer
Sold on a plan
3,552
$29.05
$103.19K
David Bredt
17 Feb 2026
Chief Scientific Officer
Sold on a plan
2,200
$29.59
$65.11K
David Bredt
17 Feb 2026
Chief Scientific Officer
Sold on a plan
5,400
$28.95
$156.33K
David Bredt
17 Feb 2026
Chief Scientific Officer
Sold on a plan
900
$28.02
$25.22K
Abraham Ceesay
20 Jan 2026
Chief Executive Officer
Sold on a plan indirect
5,083
$26.11
$132.74K
Abraham Ceesay
20 Jan 2026
Chief Executive Officer
Sold on a plan
5,833
$26.12
$152.33K
David Bredt
15 Jan 2026
Chief Scientific Officer
Sold on a plan
200
$27.40
$5.48K
David Bredt
15 Jan 2026
Chief Scientific Officer
Sold on a plan
8,300
$26.83
$222.65K
Abraham Ceesay
17 Dec 2025
Chief Executive Officer
Sold on a plan indirect
515
$31.04
$15.99K
Abraham Ceesay
17 Dec 2025
Chief Executive Officer
Sold on a plan indirect
2,421
$30.04
$72.72K
Abraham Ceesay
17 Dec 2025
Chief Executive Officer
Sold on a plan indirect
2,147
$28.84
$61.92K
Abraham Ceesay
17 Dec 2025
Chief Executive Officer
Sold on a plan
600
$31.04
$18.62K
Abraham Ceesay
17 Dec 2025
Chief Executive Officer
Sold on a plan
2,792
$30.04
$83.86K
Abraham Ceesay
17 Dec 2025
Chief Executive Officer
Sold on a plan
2,441
$28.84
$70.39K
David Bredt
15 Dec 2025
Chief Scientific Officer
Sold on a plan
796
$30.68
$24.42K
David Bredt
15 Dec 2025
Chief Scientific Officer
Sold on a plan
7,704
$29.95
$230.71K
David Bredt
17 Nov 2025
Chief Scientific Officer
Sold on a plan
5,344
$25.39
$135.70K
David Bredt
17 Nov 2025
Chief Scientific Officer
Sold on a plan
3,156
$24.84
$78.39K
Abraham Ceesay
17 Nov 2025
Chief Executive Officer
Sold on a plan indirect
2,841
$25.44
$72.27K
Abraham Ceesay
17 Nov 2025
Chief Executive Officer
Sold on a plan indirect
2,242
$24.91
$55.85K
Abraham Ceesay
17 Nov 2025
Chief Executive Officer
Sold on a plan
3,056
$25.43
$77.71K
Abraham Ceesay
17 Nov 2025
Chief Executive Officer
Sold on a plan
2,777
$24.92
$69.22K
Abraham Ceesay
15 Oct 2025
Chief Executive Officer
Sold on a plan indirect
755
$26.17
$19.76K
Abraham Ceesay
15 Oct 2025
Chief Executive Officer
Sold on a plan indirect
4,328
$25.75
$111.43K
Abraham Ceesay
15 Oct 2025
Chief Executive Officer
Sold on a plan
1,186
$26.14
$31.00K
Abraham Ceesay
15 Oct 2025
Chief Executive Officer
Sold on a plan
4,647
$25.72
$119.54K
David Bredt
15 Oct 2025
Chief Scientific Officer
Sold on a plan
1,082
$26.16
$28.31K
David Bredt
15 Oct 2025
Chief Scientific Officer
Sold on a plan
7,418
$25.73
$190.89K
Abraham Ceesay
17 Sep 2025
Chief Executive Officer
Sold on a plan indirect
700
$27.04
$18.93K
Abraham Ceesay
17 Sep 2025
Chief Executive Officer
Sold on a plan indirect
34,885
$26.30
$917.54K
Abraham Ceesay
17 Sep 2025
Chief Executive Officer
Sold on a plan
1,400
$26.87
$37.62K
Abraham Ceesay
17 Sep 2025
Chief Executive Officer
Sold on a plan
39,435
$26.30
$1.04M
David Bredt
15 Sep 2025
Chief Scientific Officer
Sold on a plan
3,402
$24.66
$83.89K
David Bredt
15 Sep 2025
Chief Scientific Officer
Sold on a plan
5,098
$23.88
$121.76K
David Bredt
15 Aug 2025
Chief Scientific Officer
Sold on a plan
200
$15.79
$3.16K
David Bredt
15 Aug 2025
Chief Scientific Officer
Sold on a plan
8,300
$14.98
$124.31K
David Bredt
15 Jul 2025
Chief Scientific Officer
Sold on a plan
8,500
$14.00
$118.96K
David Bredt
16 Jun 2025
Chief Scientific Officer
Sold on a plan
8,500
$11.00
$93.52K
David Bredt
15 May 2025
Chief Scientific Officer
Sold on a plan
8,500
$9.56
$81.26K
David Bredt
15 Apr 2025
Chief Scientific Officer
Sold on a plan
8,500
$9.57
$81.31K
David Bredt
14 Mar 2025
Chief Scientific Officer
Sold on a plan
8,500
$10.85
$92.21K
Show all 128 transactions →

What was left out

Form 4 filings counted 101
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 87
Sales straight out of an exercise 2
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 14,127,701
History held since 10 Jun 2024